← Browse by Condition
Medical Condition

breast cancer metastatic

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2
NCT06298084 Phase 1, Phase 2
Recruiting

Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd

Enrollment
152 pts
Location
France
Sponsor
Gustave Roussy, Cancer Campus,...
View Trial →
NCT07154563
Recruiting

Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer

Enrollment
60 pts
Location
China
Sponsor
Yunnan Cancer Hospital
View Trial →
NCT06891651
Recruiting

21-gene in Elder Breast Cancer Patients With Lymph Node Metastasis

Enrollment
35 pts
Location
China
Sponsor
Qilu Hospital of Shandong Univ...
View Trial →
NCT07007559 Phase 1, Phase 2
Recruiting

ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies

Enrollment
80 pts
Location
United States
Sponsor
ALX Oncology Inc.
View Trial →
NCT06706570
Recruiting

PIK3CA Mutational Status Assessment

Enrollment
100 pts
Location
Italy
Sponsor
European Institute of Oncology
View Trial →